US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Research & Development Market Research Reports & Industry Analysis

The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.

New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.

Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.

RSS Feeds

Research & Development Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Clinical Trails Market in India - 2014
10/13/2014 | published by: Feedback Business Consulting Services Pvt. Ltd.
... in India for FY14 Share of Clinical Trials Registered in Asia No. of Trials Registered in India Distribution of Trials on basis of Phase Trials on basis of Therapeutic Areas Providing insights into Industry drivers ...  |  read more...
USD 4,000
Conference Documentation: Orphan Drugs and Rare Diseases
10/20/2014 | published by: SMI Publishing, Ltd
... companies now looking to orphan drugs as an essential revenue stream with 2014 set to be the year to see Orphan adoption! As of January 2014, the EMA lifted the restriction on providing fee reductions ...  |  read more...
USD 788.78
EpiCast Report: Cushing’s Syndrome - Epidemiology Forecast to 2023
10/27/2014 | published by: GlobalData
... hormone produced by the adrenal glands that has many functions in the body, such as anti-inflammatory action, antiallergic action, antianabolic action, and amino acid catabolic action. CS is associated with increased mortality caused by complications ...  |  read more...
USD 3,995
Plunkett's Biotech & Genetics Industry Almanac 2015: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
10/25/2014 | published by: Plunkett Research, Ltd.
... trends analysis, market data and competitive intelligence Market forecasts and Industry Statistics Industry Associations and Professional Societies List In-Depth Profiles of hundreds of leading companies Industry Glossary Buyer may register for free access to search ...  |  read more...
USD 349.99
EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023
10/27/2014 | published by: GlobalData
... habit. Due to the lack of a demonstrable structural abnormality to explain these symptoms, IBS is classified as a functional gastrointestinal disorder. IBS is one of the most common gastrointestinal disorders; moreover, it has a ...  |  read more...
USD 3,995
Malignant Melanoma: KOL Insight
10/17/2014 | published by: FirstWord
... would prescribe them, and the factors likely to affect their future positioning and competitiveness. The recent US approval of Merck's PD-1 inhibitor Keytruda (pembrolizumab) and the expected approval of BMS' Opdivo (nivolumab) are ushering in ...  |  read more...
USD 6,495
Orphan Drug Market Access: Payer Insights on the Present and Future
10/14/2014 | published by: FirstWord
... the orphan drug sector. The number of orphan drug approvals is growing and access for patients is wide. There is little by way of price constraint with cost per patient year exceeding US$300,000 in some ...  |  read more...
USD 495
Global ADHD Drugs Market 2014-2018
10/22/2014 | published by: TechNavio - Infiniti Research Ltd.
... from several problems including hyperactivity, impulsiveness, and lack of focus and concentration. The causes of ADHD are not known. It is believed to be linked with genetic and environmental causes. However, it has been reported ...  |  read more...
USD 2,500
Alzheimer's Disease Drugs Markets in China
11/1/2014 | published by: Asia Market Information & Development Company
... The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines ...  |  read more...
USD 4,000
Research Report on China Foot-and-mouth Disease (FMD) Vaccine Industry : 2014-2018
9/17/2014 | published by: China Research and Intelligence Co., Ltd.
... statistics of agricultural production from the National Bureau of Statistics of China, the annual output volume of poultry meat was 83.73 million tons in 2013, up by 1.8% YOY. The output volume of pork was ...  |  read more...
USD 1,800
Medical Market Research in the United Kingdom
10/2/2014 | published by: Plimsoll Publishing Ltd.
... and ADELPHI GROUP LTD. Covering activities such as health, medical market research, kite, linguistic validation of a clinical trial questionnaire, occupational physiotherapy and includes a wealth of information on the financial trends over the past ...  |  read more...
USD 525
Medical and Scientific Research, Global
10/2/2014 | published by: Plimsoll Publishing Ltd.
... and ARM LIMITED. This report includes a wealth of information on the financial trends over the past four years. latest Medical & Scientific Research Global analysis is perfect for investors to: See the market leaders ...  |  read more...
USD 1,425
Medical and Scientific Research in Europe
10/2/2014 | published by: Plimsoll Publishing Ltd.
... NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO and CBMM EUROPE B.V.. This report includes a wealth of information on the financial trends over the past four years. latest Medical & Scientific Research European analysis is perfect ...  |  read more...
USD 1,200
Medical & Scientific Research (Global) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 500 largest Medical & Scientific Research (Global) companies. The Medical & Scientific Research (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their ...  |  read more...
USD 1,520
Medical & Scientific Research (European) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 500 largest Medical & Scientific Research (European) companies. The Medical & Scientific Research (European) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their ...  |  read more...
USD 1,280
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
9/22/2014 | published by: MarketsandMarkets
... the years, the cell line development market has witnessed various technological advancements in order to cater to the growing demand for stable and high-yielding cell lines. These advancements have led to growth in a number ...  |  read more...
USD 4,650
Research Report on China Swine Fever Vaccine Industry : 2014-2018
9/17/2014 | published by: China Research and Intelligence Co., Ltd.
... pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, ...  |  read more...
USD 1,800
RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019
9/26/2014 | published by: MarketsandMarkets
... expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past ...  |  read more...
USD 4,650
Business Strategy: Disruptive Innovation — Transformational Change Coming in Life Science R&D
10/6/2014 | published by: IDC
... operational efficiency and excellence a continuing mantra driving near-term organizational investments, there are few remaining incremental improvements that can deliver the level of cost savings and improved productivity that companies are looking for. While likely ...  |  read more...
USD 4,500
Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry : 2014-2018
9/17/2014 | published by: China Research and Intelligence Co., Ltd.
... of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock ...  |  read more...
USD 1,800
Influenza A Infections - Pipeline Review, H2 2014
9/30/2014 | published by: Global Markets Direct
... information on the therapeutic development for Influenza A Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Best Practices - Lessons Learned from IT Outsourcing in the Life Science R&D Space
9/22/2014 | published by: IDC
... of BPO, ITO, and strategic consulting projects in the life science R&D space. The lessons learned were gleaned from interviews with 35 executives from leading top-tier and midtier global life science companies, research compiled into ...  |  read more...
USD 4,500
Clinical Research in the United Kingdom
10/2/2014 | published by: Plimsoll Publishing Ltd.
... Covering activities such as clinical trials, cro, biotechnology, clinical research, pharmaceutical development and includes a wealth of information on the financial trends over the past four years. latest Clinical Research analysis is perfect for investors ...  |  read more...
USD 525
Physician Views: Can Portola's reversal agent act as growth catalyst for novel anticoagulants?
10/8/2014 | published by: FirstWord
... patients who have received therapy with a Factor Xa inhibitor, but whom subsequently need the anticoagulant action to be reversed due to bleeding or the requirement for surgery. Portola's assertion that andexanet alfa will meet ...  |  read more...
USD 645
Bioscience (UK) - Industry Report
10/7/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 240 largest Bioscience (UK) companies. The Bioscience (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises ...  |  read more...
USD 560
< prev 1    3  4  5  6  7  8  9  10